Personalized Breast Cancer Treatment

  • Visiting address


Unit profile


Breast cancer is a heterogeneous disease with differences in clinical outcome and sensitivity to treatment. The choice of treatment after surgery (radiotherapy, antibodies, endocrine or chemo) is based on prognostic (risk of recurrence) and treatment predictive (choice of treatment) factors. About two thirds are cured after surgery, and still about 90% receive additional treatment. This means that some patients are over treated, but at the same time the treatment is lifesaving for others. It is extremely important to identify patients in need of additional treatment and, when needed, to choose the correct treatment. We are working towards new ways of looking at the information already collected and evaluated in the clinical routine but we’re also trying to identify new factors with both conventional techniques (e.g. immunohistochemistry) and new techniques (e.g. sequencing) that will help clinicians deciding what treatment or treatment combination will be best for the individual patient.

UKÄ subject classification

  • Cancer and Oncology

Free keywords

  • Breast cancer
  • prognosis
  • prediction
  • biomarkers
  • treatment

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or